当前位置:首页 - 行情中心 - 泰格医药(300347) - 财务分析 - 现金流量表

泰格医药

(300347)

  

流通市值:257.59亿  总市值:393.11亿
流通股本:5.60亿   总股本:8.55亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金6,306,144,935.694,111,313,981.512,034,062,055.587,252,500,492.85
  收到的税费返还17,484,419.6317,056,864.282,677,768.2318,708,343.13
  收到其他与经营活动有关的现金111,266,621.3154,184,102.1353,706,326.07100,557,127.06
  经营活动现金流入小计6,434,895,976.634,182,554,947.922,090,446,149.887,371,765,963.04
  购买商品、接受劳务支付的现金2,052,754,376.61,321,495,382.25654,921,629.082,385,493,371.31
  支付给职工以及为职工支付的现金2,672,917,939.441,828,304,817.5811,053,535.183,201,531,424.16
  支付的各项税费448,166,533.31338,391,468.73111,725,928.93391,733,866.32
  支付其他与经营活动有关的现金489,745,203.83268,580,944.15195,041,280.33274,922,530.71
  经营活动现金流出小计5,663,584,053.183,756,772,612.631,772,742,373.526,253,681,192.5
  经营活动产生的现金流量净额771,311,923.45425,782,335.29317,703,776.361,118,084,770.54
二、投资活动产生的现金流量:
  收回投资收到的现金1,415,438,668.24859,983,284.4353,734,657.822,190,670,618.94
  取得投资收益收到的现金334,203,700.27250,455,802.79118,504,208.43639,151,660.33
  处置固定资产、无形资产和其他长期资产收回的现金净额651,986.93467,631.24275,166.525,933,203.19
  收到的其他与投资活动有关的现金41,000,000--67,746,984.31
  投资活动现金流入小计1,791,294,355.441,110,906,718.43472,514,032.772,903,502,466.77
  购建固定资产、无形资产和其他长期资产支付的现金131,139,268.95106,102,426.950,430,337.37214,369,102.48
  投资支付的现金1,738,352,529.11949,339,788.82338,564,515.281,915,690,187.33
  取得子公司及其他营业单位支付的现金400,000400,000400,000164,946,844.98
  支付其他与投资活动有关的现金6,252,217.76,252,217.728,882,924.28116,939,779.75
  投资活动现金流出小计1,876,144,015.761,062,094,433.42418,277,776.932,411,945,914.54
  投资活动产生的现金流量净额-84,849,660.3248,812,285.0154,236,255.84491,556,552.23
三、筹资活动产生的现金流量:
  吸收投资收到的现金223,050,000166,913,467.37114,736,849.16223,654,000
  其中:子公司吸收少数股东投资收到的现金-166,913,467.37--
  取得借款收到的现金1,213,764,354.771,169,980,559.5234,127,7001,137,864,305.84
  收到其他与筹资活动有关的现金16,295,140.682,140,799.6-60,576,000
  筹资活动现金流入小计1,453,109,495.451,339,034,826.47348,864,549.161,422,094,305.84
  偿还债务支付的现金587,019,853.36408,214,609.43158,269,636.32,373,696,294.1
  分配股利、利润或偿付利息支付的现金192,199,533.4769,717,365.8714,967,990.38343,659,038.48
  其中:子公司支付给少数股东的股利、利润-30,568,995.29--
  支付其他与筹资活动有关的现金1,012,308,655.35991,682,109.58168,051,754.39631,424,182.78
  筹资活动现金流出小计1,791,528,042.181,469,614,084.88341,289,381.073,348,779,515.36
  筹资活动产生的现金流量净额-338,418,546.73-130,579,258.417,575,168.09-1,926,685,209.52
四、汇率变动对现金及现金等价物的影响-30,244,682.58-23,544,743.26-14,454,893.77-8,841,588.41
五、现金及现金等价物净增加额317,799,033.82320,470,618.63365,060,306.52-325,885,475.16
  加:期初现金及现金等价物余额1,722,608,377.681,722,608,377.681,722,608,377.682,048,493,852.84
  期末现金及现金等价物余额2,040,407,411.52,043,078,996.312,087,668,684.21,722,608,377.68
补充资料:
  净利润--185,471,319.77-805,056,174.52
  资产减值准备-877,227.81-37,043,406.56
  固定资产和投资性房地产折旧-73,408,629.08-133,420,590.25
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-73,408,629.08-133,420,590.25
  无形资产摊销-37,963,678.18-78,338,419.78
  长期待摊费用摊销-22,070,533.96-42,809,046.7
  处置固定资产、无形资产和其他长期资产的损失-18,083,068.74--3,650,548.27
  固定资产报废损失---1,089,100.07
  公允价值变动损失-443,323,794.17--42,256,274.39
  财务费用-42,390,160.85-107,509,287.27
  投资损失-2,431,886.75--433,815,899.7
  递延所得税--5,614,772.27--48,218,232.93
  其中:递延所得税资产减少--3,939,037.85--18,142,797.11
    递延所得税负债增加--1,675,734.42--30,075,435.82
  存货的减少--25,023,970.59--9,516,013.06
  经营性应收项目的减少--107,962,153.27--199,801,117.54
  经营性应付项目的增加-56,834,672.08-511,487,999.77
  其他-4,742,685.45-23,680,964.04
  现金的期末余额-2,043,078,996.31-1,722,608,377.68
  减:现金的期初余额-1,722,608,377.68-2,048,493,852.84
  现金及现金等价物的净增加额-320,470,618.63--325,885,475.16
公告日期2026-10-302026-08-292026-04-292026-03-31
审计意见(境内)标准无保留意见
TOP↑